Search research articles
Contact Us
Filters
Showing results (21-30 of 52) with videos related to
Page
of 6
Sort By:
British Journal of Pharmacology
|
January 12, 1999
Modulation of AT1 receptor-mediated contraction of rat uterine artery by AT2 receptors
A S Zwart, E A Davis, R E Widdop
European Journal of Pharmacology
|
August 29, 1996
Vascular reactivity to angiotensin II in blood-perfused kidneys of hypertensive diabetic rats
N K Farina, W C Hodgson, R E Widdop
Neuroscience Letters
|
October 16, 1987
Non-invasive tests of neurovascular function: reduced responses in diabetes mellitus
R A Westerman, R E Widdop, C Hogan, et al.
Clinical Science (London, England : 1979)
|
September 28, 1998
A comparison of the development of renal hypertension in male and female rats
R Okuniewski, E A Davis, B Jarrott, et al.
The American Journal of Physiology
|
January 1, 1993
Central administration of PD 123319 or EXP-3174 inhibits effects of angiotensin II
R E Widdop, S M Gardiner, P A Kemp, et al.
British Journal of Pharmacology
|
March 1, 1993
Comparison of the regional haemodynamic effects of the AT1-receptor antagonists, losartan and EXP 3174, in water-deprived Brattleboro rats
R E Widdop, S M Gardiner, P A Kemp, et al.
Neuroscience
|
September 17, 2005
Minocycline treatment attenuates microglia activation and non-angiotensin II [125I] CGP42112 binding in brainstem following nodose ganglionectomy
C L Roulston, A J Lawrence, R E Widdop, et al.
The American Journal of Physiology
|
July 1, 1993
Differential blockade of central effects of angiotensin II by AT2-receptor antagonists
R E Widdop, S M Gardiner, P A Kemp, et al.
European Journal of Pharmacology
|
September 4, 1990
The effect of ketanserin on cardiovascular reflexes in conscious normotensive and spontaneously hypertensive rats
R E Widdop, A J Verberne, W J Louis, et al.
British Journal of Pharmacology
|
November 1, 1992
Inhibition of the haemodynamic effects of angiotensin II in conscious rats by AT2-receptor antagonists given after the AT1-receptor antagonist, EXP 3174
R E Widdop, S M Gardiner, P A Kemp, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 52) with videos related to
Sort By:
Page
of 6
British Journal of Pharmacology
|
January 12, 1999
Modulation of AT1 receptor-mediated contraction of rat uterine artery by AT2 receptors
A S Zwart, E A Davis, R E Widdop
European Journal of Pharmacology
|
August 29, 1996
Vascular reactivity to angiotensin II in blood-perfused kidneys of hypertensive diabetic rats
N K Farina, W C Hodgson, R E Widdop
Neuroscience Letters
|
October 16, 1987
Non-invasive tests of neurovascular function: reduced responses in diabetes mellitus
R A Westerman, R E Widdop, C Hogan, et al.
Clinical Science (London, England : 1979)
|
September 28, 1998
A comparison of the development of renal hypertension in male and female rats
R Okuniewski, E A Davis, B Jarrott, et al.
The American Journal of Physiology
|
January 1, 1993
Central administration of PD 123319 or EXP-3174 inhibits effects of angiotensin II
R E Widdop, S M Gardiner, P A Kemp, et al.
British Journal of Pharmacology
|
March 1, 1993
Comparison of the regional haemodynamic effects of the AT1-receptor antagonists, losartan and EXP 3174, in water-deprived Brattleboro rats
R E Widdop, S M Gardiner, P A Kemp, et al.
Neuroscience
|
September 17, 2005
Minocycline treatment attenuates microglia activation and non-angiotensin II [125I] CGP42112 binding in brainstem following nodose ganglionectomy
C L Roulston, A J Lawrence, R E Widdop, et al.
The American Journal of Physiology
|
July 1, 1993
Differential blockade of central effects of angiotensin II by AT2-receptor antagonists
R E Widdop, S M Gardiner, P A Kemp, et al.
European Journal of Pharmacology
|
September 4, 1990
The effect of ketanserin on cardiovascular reflexes in conscious normotensive and spontaneously hypertensive rats
R E Widdop, A J Verberne, W J Louis, et al.
British Journal of Pharmacology
|
November 1, 1992
Inhibition of the haemodynamic effects of angiotensin II in conscious rats by AT2-receptor antagonists given after the AT1-receptor antagonist, EXP 3174
R E Widdop, S M Gardiner, P A Kemp, et al.
Page
of 6